30 results
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded … to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
424B5
NEXI
Neximmune Inc
5 Feb 24
Prospectus supplement for primary offering
4:34pm
regarding issuers that file electronically with the SEC, including us. The address of the SEC website is www.sec.gov. Additionally, you may access … maintain a website at www.neximmune.com, through which you can access our SEC filings. The information set forth on our website is not part
PRE 14A
gspgmu5hoqmyvql
13 Sep 23
Preliminary proxy
5:14pm
8-K
EX-1.1
lauoi hjt
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
424B5
scy6o767y hwy
17 Jun 22
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
5ybprb 7pi2
12 May 22
NexImmune Reports First Quarter 2022 Financial Results and Provides Business Updates
4:16pm
DEF 14A
p6o7s
3 May 22
Definitive proxy
4:16pm
S-3
3zz8604 dsm26b9
9 Mar 22
Shelf registration
5:14pm
10-Q
710y7y2009 27e
17 May 21
Quarterly report
4:14pm
10-K
37kp26 ycy
31 Mar 21
Annual report
4:02pm
424B4
b3o017748qr49h
16 Feb 21
Prospectus supplement with pricing info
4:38pm